Company Information

  

Address: 11075 ROSELLE STREET  
City: San Diego 
State: CA 
Zip Code: 92121 
Telephone: 858-366-6900 

Description of Business

Primary SIC Code: 3841
(As filed with the SEC)  

We are a medical device company with an innovative approach to the design, development and commercialization of products for people with insulin-dependent diabetes. We believe our competitive advantage is rooted in our unique consumer-focused approach, and the incorporation of modern and innovative technology into our product offerings. Our manufacturing and sales activities primarily focus on our flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, which is based on our proprietary technology platform. The simple-to-use t:slim X2 is the smallest durable insulin pump available, and the only pump currently available that is capable of remote feature updates, which positions us well to address the evolving needs and preferences of differentiated segments of the insulin-dependent diabetes market.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2018-4.07NAN/E
03/2018-7.23NAN/E
12/2017-12.87NAN/E
09/2017-185.70NAN/E
06/2017-256.00NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.16Total Liab/Total Assets1.31
Net Inc/Total Assets-0.77Total Liab/Inv Cap2.10
Net Inc/Inv Cap-1.23Total Liab/Comm Equity0.28
Pretax Inc/Net Sales-0.68Interest Coverage Ratio-5.44
Net Inc/Net Sales-0.68Curr Debt/EquityNA
Cash Flow/Net Sales-0.61LTD/Equity-2.63
SG&A/NetSales0.80Total Debt/Equity-2.63
Asset Utilization   Liquidity  
Net Receivables Turnover6.73Quick Ratio1.03
Inventory Turnover2.64Current Ratio1.78
Inventory Day Sales0.01Net Rec/Curr Assets0.32
Net Sales/Work Cap3.83Inv/Curr Assets0.42
Net Sales/PP&E5.48  

Income Statement (Millions)

  6/30/2018 3/31/2018 12/31/2017 9/30/2017
Total Revenues(Net Sales) 34.13 27.28 40.30 27.00
Cost of Goods Sold 19.04 15.87 22.83 15.13
Selling & Admin Exps 22.63 20.91 21.30 20.13
Operating Income -14.00 -15.49 -9.58 -13.17
Interest Exp 3.11 3.07 2.90 2.93
Pretax Income -59.36 -32.69 -11.40 -16.03
Other Income -42.25 -14.14 1.08 0.06
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -59.36 -32.69 -11.41 -16.03

Balance Sheet (Millions)

Assets 6/30/2018 3/31/2018 12/31/2017 9/30/2017
Cash & Short Term Investments 86.51 71.88 14.18 12.54
Receivables - Total 13.91 13.04 20.79 10.58
Inventories - Total 24.91 26.49 26.99 29.99
Total Current Assets 128.34 114.34 64.16 55.99
Net Property, Plant & Equipment 18.21 18.86 19.63 20.29
Total Assets 157.99 144.70 95.35 87.98
Liabilities        
Accounts Payable 21.57 17.46 22.47 21.55
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 42.51 43.71 36.09 29.41
Long-Term Debt 77.10 76.41 76.54 75.60
Total Liabilities 131.99 132.85 124.49 115.94
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.05 0.05 0.01 0.06
Retained Earnings -569.52 -510.16 -477.61 -466.21
Treasury Stock NA NA NA NA
Total Stockholders' Equity 26.01 11.85 -29.15 -27.96
Total Liabilities and Stockholders' Equity 157.99 144.70 95.35 87.98

Cash Flow Summary (Millions)

Categories 6/30/2018 3/31/2018 12/31/2017 9/30/2017
Net Cash Provided by Operating Activities -6.72 -12.27 -11.64 -19.02
Net Cash Provided by Investing Activities -27.82 -9.51 -1.42 -0.24
Net Cash Provided by Financing Activities 22.51 70.67 14.68 -4.01

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201329.01-63.14--
12/201449.72-79.52--
12/201572.85-72.42--
12/201684.25-83.45--
12/2017107.60-73.03-12.87
Growth Rates38.78----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/1813433,38158.34




Report Date : 9/24/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.